CAS RN: 1161847-28-4
4,6-dichloropyridazin-3-amine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260621
100mg / 250mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1161847-28-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1161847-28-4 / 4,6-dichloropyridazin-3-amine
4,6-dichloropyridazin-3-amine | RefChem:508035 | 859-795-5
Standard CAS: 1161847-28-4
Multi CAS: No
Basic Information
copy
CAS
1161847-28-4 copy
Multi CAS
No copy
Molecular Formula
C4H3Cl2N3 copy
Molecular Weight
163.990000 copy
Exact Mass
162.970403 copy
SMILES
C1=C(C(=NN=C1Cl)N)Cl copy
InChI
InChI=1S/C4H3Cl2N3/c5-2-1-3(6)8-9-4(2)7/h1H,(H2,7,9) copy
InChIKey
KHWQTMSISRCANV-UHFFFAOYSA-N copy
Synonyms
4,6-dichloropyridazin-3-amine
RefChem:508035
859-795-5
3-Pyridazinamine, 4,6-dichloro-
4,6-dichloro-3-Pyridazinamine copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Aromatic heavy atom count
6 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
36.46 copy
TPSA
51.8 copy
LogP / Solubility
WLOGP
1.37 copy
MLOGP
1.2 copy
XLogP3
1.1 copy
Consensus LogP
1.22 copy
Log S (ESOL)
-2.21 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.89 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.86 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.75 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
Pictogram(s)
Irritant copy
Signal
Warning copy
GHS Hazard Statements
H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] copy
Precautionary Statement Codes
P264+P265, P280, P302+P352, P305+P351+P338, P317, P321, P337+P317, P362+P364, and P501 copy